Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    Military Issues RFI for ‘Virus Like Particle’ Vaccine Production

    By Global Biodefense StaffMay 29, 2012
    Share
    Facebook LinkedIn Reddit Email

    The Chemical Biological Medical Systems Joint Vaccine Acquisition Program (CBMS-JVAP) is the organization responsible for developing, producing and stockpiling FDA-licensed vaccine systems to protect the military personnel from biological agents. The current CBMS-JVAP portfolio includes vaccines at varying stages of clinical development in addition to FDA licensed vaccines. 

    CBMS-JVAP yesterday issued a Request for Information (RFI) seeking input from manufacturers with the capability to deliver a Good Manufacturing Practices (GMP) product that will be suitable for use in humans by the government to support non-clinical and Phase 1 studies under an Investigational New Drug (IND) application. Specifically, the government is seeking a manufacturer with the capability to conduct manufacturing of government owned Virus Like Particles (VLPs) vaccines. The government plans to initiate manufacturing efforts in early 2013.

    Companies with the experience and the capability to develop, manufacture and produce a VLP vaccine under cGMP manufacturing conditions are invited to respond to the RFI.

    Further details are available under Solicitation Number: W911QY-12-S-0018. The response deadline is June 13, 2012.

    JPEO-CBRND RFI Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleFBI Study Raises More Questions in Bruce Ivins Anthrax Case
    Next Article U.S. Customs to Increase Food Testing Capabilities with AB Sciex

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023

    Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve

    September 13, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.